Welcome to our dedicated page for NFNTWS news (Ticker: NFNTWS), a resource for investors and traders seeking the latest updates and insights on NFNTWS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NFNTWS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NFNTWS's position in the market.
Infinite Acquisition Corp. has successfully closed its initial public offering of 27,600,000 units at
Infinite Acquisition Corp. announced the pricing of its IPO, offering 24,000,000 units at $10.00 each, set to trade on the NYSE under the symbol NFNT.U starting November 19, 2021. Each unit comprises one Class A ordinary share and half a redeemable warrant, with the warrants allowing purchase of shares at $11.50. The IPO, co-sponsored by Thirty Five Ventures and LionTree, targets technology-enabled platforms in various sectors. Credit Suisse acts as the sole underwriter, with an option for an additional 3,600,000 units. Closing is expected on November 23, 2021.
